Navigation Links
MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
Date:11/30/2007

Company to Report Interim Celgosivir 4-Week Viral Kinetics Study Data on

Monday December 3, 2007

VANCOUVER and SAN DIEGO, Nov. 30 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious diseases, will host a conference call and webcast on Thursday, December 13, 2007 at 11:00 a.m. ET (8:00 a.m. PT) to discuss financial results for the second fiscal quarter ended October 31, 2007 and provide an update on company activities. To participate in the conference call, please dial 416-644-3418 or 1-800-732-1073. The call will be available for replay until December 27, 2007 by calling 416-640-1917 or 1-877-289-8525 and entering the pass code 21255722 (followed by the number sign). The live and archived webcast can be accessed through the company's website at http://www.migenix.com for the next 90 days.

Additionally, the Company will report interim 4-week data from a Phase II viral kinetics combination study of celgosivir in patients with chronic HCV (genotype 1) infection on Monday December 3, 2007.

About MIGENIX

MIGENIX is committed to advancing therapy, improving health, and enriching life by developing and commercializing drugs primarily in the area of infectious diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C infections (Phase II and preclinical), the prevention of catheter-related infections (Phase III) and the treatment of dermatological diseases (Phase II). MIGENIX is headquartered in Vancouver, British Columbia, Canada with US operations in San Diego, California. Additional information can be found at http://www.migenix.com.

"Jim DeMesa"

James M. DeMesa, M.D.

President & CEO

CONTACT: Art Ayres, MIGENIX Inc., Tel: (604) 221-9666 Ext. 233, aayres@migenix.com; Dian
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
2. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
3. MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
4. MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
5. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
8. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Carrington Reports Second Quarter 2007 Results
11. Response Genetics Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Green Earth Energy has restructured their waste and ... Waste to Energy system. Paul Douglas of Green ... http://www.greenearthwaste.com which has been operating in West ... their waste collection services in 2012 and continues to ... companies with manufacturing plants in West Tennessee. Green ...
(Date:6/3/2015)... New York and London (PRWEB) June 03, 2015 ... Applications (NCSA) recently set a new world record ... 102,000 cores on the Blue Waters supercomputer. ... tool used across many industries to stimulate innovation ... NCSA’s Private Sector Program and Blue Waters manufacturer ...
(Date:6/3/2015)... NC (PRWEB) June 03, 2015 ... the issuance of US Patent No. 9,044,273, underpinning ... improving the thoraco-lumbar spinal fusion implant procedure by ... them with one easy-to-use disposable instrument tray. The ... for numerous benefits over previous technology. Intelligent Implant ...
(Date:6/2/2015)... , June 2, 2015 /PRNewswire/ - Aptose Biosciences Inc. ... developing new therapeutics that target the underlying mechanisms of ... Administration (FDA) has granted the company orphan drug designation ... (AML). APTO-253, a first-in-class inducer of the KLF4 gene, ... Ib clinical trial in patients with AML, high-risk myelodysplastic ...
Breaking Biology Technology:NCSA Scales CD-adapco’s STAR-CCM+ to New World Record of 102,000 Cores on Blue Waters 2NCSA Scales CD-adapco’s STAR-CCM+ to New World Record of 102,000 Cores on Blue Waters 3Intelligent Implant Systems Announces US Patent Attained for Revolution™ Spinal System 2Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 2Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 3Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 4
... tiny scaffolds to be used as delivery vehicles to drop ... as Alzheimer,s and Parkinson,s. Owing to the versatility and ... facilitating the growth of cells and could be designed specifically ... In their study published today, Tuesday 20 September, ...
... The Southeastern Universities Research Association today announced that Neal ... and former chief White House science advisor, would receive ... Board meeting on November 9. The award honors ... of strengthening the scientific and technical capabilities of the ...
... WORCESTER, Mass. and TORONTO, Sept. 19, 2011 ... wholly-owned subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ), ... for the treatment of breast, prostate, and other ... of Expert Opinion on Biological Therapy , ...
Cached Biology Technology:Lasers light the path to neuron regeneration 2SURA to honor former NSF director, White House science advisor 2SURA to honor former NSF director, White House science advisor 3Antigen Express Cancer Vaccine Highlighted in Expert Opinion on Biological Therapy 2Antigen Express Cancer Vaccine Highlighted in Expert Opinion on Biological Therapy 3Antigen Express Cancer Vaccine Highlighted in Expert Opinion on Biological Therapy 4Antigen Express Cancer Vaccine Highlighted in Expert Opinion on Biological Therapy 5
(Date:5/22/2015)... -- According to a new market research ... Emotion, Forensic), by Software (Middleware, Databases), by Hardware (Cameras, Integrated ... Home) - Global Forecast to 2020", published by MarketsandMarkets, ... 2015 to $6.19 Billion by 2020, at a CAGR ... Tables and   43 Figures spread through 140 Pages ...
(Date:5/21/2015)... , May 21, 2015 The ... potential of music for health, today announced a collaborative ... . The partnership will center on collaboration on original ... a first step in the collaboration, The Sync Project ... on "Music as Medicine" in the 2015-2016 academic year.  ...
(Date:5/20/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... LLC, a company engaged in biometric identification is an ... portion of the recently awarded TIES (Technical Information Engineering ... Army. 3D-ID LLC has a suite of ... and security agencies. Gino Pereira , ...
Breaking Biology News(10 mins):Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3
... By using a new analysis method, researchers at Karolinska Institutet ... close to one hundred novel human gene regions that code ... which may be linked to cancer. The expectation is now ... scientific journal Nature Methods , will open up a ...
... international team spearheaded by researchers from the University of ... at particularly high risk of serious asthma attacks, including ... disease. In the long term, these new findings are ... which represents a high cost for families and society ...
... years ago the Earth system was recovering from perhaps the ... the atmosphere and oceans. This led to a series ... around Aivo Lepland of the Norwegian Geological Survey NGU reports ... This also resulted in the distribution of one of life,s ...
Cached Biology News:Protein coding 'junk genes' may be linked to cancer 2Researchers identify main genes responsible for asthma attacks in children 2Researchers identify main genes responsible for asthma attacks in children 3
IHC detection kit for BrdU in cells and tissues...
The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
Tissue culture grade....
The DNA DipStick Kit is ideal for estimating nucleic acid concentrations and approximate yields. Works with ss- and ds-DNA, RNA, and oligonucleotides at concentrations as low as 0.1 ng/l....
Biology Products: